- This blog is a discussion about the flaws in our health care system and the need for reform.
-

Blogroll
About Me
Alison Bass is a Pulitzer Prize nominee and author of Side Effects: A Prosecutor, a Whistleblower and a Bestselling Antidepressant on Trial, which won the NASW Science in Society Award. She was a longtime medical and science writer for The Boston Globe and has also written for The Miami Herald, Psychology Today and MIT's Technology Review, among other publications. A series she wrote for The Boston Globe on psychiatry was nominated for a Pulitzer Prize and she has received many other journalism awards. In 2007, she won a prestigious Alicia Patterson Fellowship to write Side Effects. Bass teaches journalism at Mount Holyoke College and Brandeis University.Blog Archive
- May 2012 (2)
- April 2012 (2)
- February 2012 (2)
- January 2012 (3)
- December 2011 (3)
- November 2011 (3)
- October 2011 (2)
- September 2011 (4)
- August 2011 (3)
- July 2011 (3)
- June 2011 (4)
- May 2011 (4)
- April 2011 (3)
- March 2011 (3)
- February 2011 (3)
- January 2011 (4)
- December 2010 (3)
- November 2010 (2)
- September 2010 (2)
- July 2010 (1)
- May 2010 (1)
- April 2010 (1)
- March 2010 (3)
- February 2010 (3)
- January 2010 (4)
- December 2009 (4)
- November 2009 (5)
- October 2009 (4)
- September 2009 (6)
- August 2009 (7)
- July 2009 (4)
- June 2009 (5)
- May 2009 (4)
- April 2009 (7)
- March 2009 (4)
- February 2009 (3)
- January 2009 (4)
- December 2008 (4)
- November 2008 (3)
- October 2008 (4)
- September 2008 (5)
- August 2008 (2)
- July 2008 (6)
- June 2008 (5)
- May 2008 (1)
- April 2008 (1)
Monthly Archives: February 2011
New study dismantles myth of high drug development costs
Share I’m embarrassed to admit that when I was a medical reporter for The Boston Globe in the ’90s, I (along with many other journalists) would unthinkingly use the $800 million that the pharmaceutical industry said it cost to develop … Continue reading
Posted in Uncategorized
10 Comments
Are we seeing a concerted drug industry campaign against the FDA?
Share There must be something in the air. Either that, or the drug and medical device industry has embarked on a concerted campaign to improve its tattered public image and bully the FDA into backing down from recent efforts to … Continue reading
Posted in Uncategorized
2 Comments
Psychiatric journal refused to retract flawed antidepressant study
Share The Journal of the American Academy of Child and Adolescent Psychiatry has refused to retract a study finding that the antidepressant Paxil was safe and effective in adolescents despite evidence of fabrication, plagiarism and failure to disclose conflicts of … Continue reading
Posted in Uncategorized
6 Comments